November 9, 2026

Infant Bleeding Cases Surge Due to Vitamin K Shot Refusal

Research highlights a significant increase in infant bleeding as more parents decline vitamin K shots. This trend reflects a growing mistrust in medical practices.

A study involving 11 million infants between 2017 and 2025 revealed a decline in administered vitamin K shots from 97.7% to 95%. Concurrently, vitamin K deficiency bleeding (VKDB) increased by 347%, according to JAMA Pediatrics.

Dr. Elizabeth Wolf, a pediatrician at Children’s Hospital of Richmond at VCU, emphasized the real-world consequences: “We found that vitamin K refusal led to a dramatic rise in VKD and VKDB.”

Vitamin K is crucial for blood clotting, yet newborns have insufficient levels. Since 1961, infants have received vitamin K shots at birth to mitigate bleeding risks. The CDC notes that vitamin K does not adequately cross the placenta, and breast milk contains minimal amounts.

The increase in VKDB mirrors issues like recent measles outbreaks, indicating a mistrust in health professionals. Dr. Wolf suggests enhanced public health messaging about vitamin K benefits.

Vitamin K deficiency can cause bruising and bleeding at the umbilicus within a week of birth. Afterward, the risk of intracranial hemorrhage rises significantly, potentially causing seizures, brain damage, or death.

The study found that 7% of infants with vitamin K deficiency and 2% with VKDB experienced brain bleeding. Ongoing monitoring of these trends is crucial, as refusal rates may influence future occurrences.

Dr. Wolf stressed the need to understand parental refusal reasons to improve vitamin K uptake.

TAGS: